Hengrui Pharmaceutical (01276.HK) rose more than 18% intraday, the share price exceeded 70 Hong Kong dollars, a record high, the company SHR-2173 injection was approved for clinical, as of now, SHR-2173 injection related projects accumulated research and development investment of about 64.07 million yuan.
2025-07-09 05:30:02
Hengrui Pharmaceutical (01276.HK) rose more than 18% intraday, the share price exceeded 70 Hong Kong dollars, a record high, the company SHR-2173 injection was approved for clinical, as of now, SHR-2173 injection related projects accumulated research and development investment of about 64.07 million yuan.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
